Blocking antibody to the β-subunit of FSH prevents bone loss by inhibiting bone resorption and stimulating bone synthesis
暂无分享,去创建一个
T. Yuen | A. Zallone | Z. Bian | Li Sun | M. Zaidi | Ling-Ling Zhu | R. Latif | T. Davies | M. New | C. Rosen | H. Blair | Lida Guo | Jay J Cao | I. Tourkova | Jianhua Li
[1] T. Yuen,et al. Blocking FSH action attenuates osteoclastogenesis. , 2012, Biochemical and biophysical research communications.
[2] M. Zaidi,et al. Translational medicine: Double protection for weakened bones , 2012, Nature.
[3] T. Kodama,et al. Osteoprotection by semaphorin 3A , 2012, Nature.
[4] A. Genazzani,et al. Skeletal status and body composition in young women with functional hypothalamic amenorrhea , 2012, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[5] M. Muñoz-Torres,et al. Role of serum FSH measurement on bone resorption in postmenopausal women , 2012, Endocrine.
[6] Li Sun,et al. Skeletal receptors for steroid‐family regulating glycoprotein hormones , 2011, Annals of the New York Academy of Sciences.
[7] C. Cheung,et al. Bone loss during menopausal transition among southern Chinese women. , 2011, Maturitas.
[8] J. Cannon,et al. Follicle-stimulating hormone promotes RANK expression on human monocytes. , 2011, Cytokine.
[9] S. Khosla,et al. Effects of suppression of follicle-stimulating hormone secretion on bone resorption markers in postmenopausal women. , 2010, The Journal of clinical endocrinology and metabolism.
[10] H. Bradshaw,et al. Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass , 2010, Proceedings of the National Academy of Sciences.
[11] S. Bhupathiraju,et al. Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation. , 2010, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.
[12] F. Gianfrancesco,et al. FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women. , 2010, European journal of endocrinology.
[13] B. Nan,et al. Amount of bone loss in relation to time around the final menstrual period and follicle-stimulating hormone staging of the transmenopause. , 2010, The Journal of clinical endocrinology and metabolism.
[14] Z. Bian,et al. Protective effects of follicle-stimulating hormone inhibitor on alveolar bone loss resulting from experimental periapical lesions in ovariectomized rats. , 2010, Journal of endodontics.
[15] Li Sun,et al. Further evidence for direct pro-resorptive actions of FSH. , 2010, Biochemical and biophysical research communications.
[16] Michael S. Landau,et al. FSH-receptor isoforms and FSH-dependent gene transcription in human monocytes and osteoclasts. , 2010, Biochemical and biophysical research communications.
[17] J. Cannon,et al. Follicle-stimulating hormone, interleukin-1, and bone density in adult women. , 2010, American journal of physiology. Regulatory, integrative and comparative physiology.
[18] M. Fan,et al. FSH Aggravates Periodontitis-related Bone Loss in Ovariectomized Rats , 2010, Journal of dental research.
[19] J. Kovach,et al. Cadmium, follicle-stimulating hormone, and effects on bone in women age 42-60 years, NHANES III. , 2010, Environmental research.
[20] H. Zhang,et al. Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women , 2010, Osteoporosis International.
[21] M. Zaidi,et al. Understanding estrogen action during menopause. , 2009, Endocrinology.
[22] M. Zaidi,et al. Evaluating the antifracture efficacy of bisphosphonates. , 2009, Reviews on recent clinical trials.
[23] H. Xie,et al. Relationship of age-related concentrations of serum FSH and LH with bone mineral density, prevalence of osteoporosis in native Chinese women. , 2009, Clinica chimica acta; international journal of clinical chemistry.
[24] S. Vukicevic,et al. Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss , 2008, Proceedings of the National Academy of Sciences.
[25] L. Lanier,et al. Bone Microenvironment Specific Roles of ITAM Adapter Signaling during Bone Remodeling Induced by Acute Estrogen-Deficiency , 2007, PloS one.
[26] Mone Zaidi,et al. Skeletal remodeling in health and disease , 2007, Nature Medicine.
[27] Li Sun,et al. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation , 2006, Proceedings of the National Academy of Sciences.
[28] A. Zallone,et al. FSH Directly Regulates Bone Mass , 2006, Cell.
[29] Daniel McConnell,et al. Hormone predictors of bone mineral density changes during the menopausal transition. , 2006, The Journal of clinical endocrinology and metabolism.
[30] Wayne A. Hendrickson,et al. Structure of human follicle-stimulating hormone in complex with its receptor , 2005, Nature.
[31] R. Little,et al. Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age. , 2004, The Journal of clinical endocrinology and metabolism.
[32] Balić Devleta,et al. Hypergonadotropic amenorrhea and bone density: new approach to an old problem , 2004, Journal of Bone and Mineral Metabolism.
[33] M. Sowers,et al. Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN , 2003, Osteoporosis International.
[34] O. Johnell,et al. A longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone mineral density. , 1995, Maturitas.
[35] T. Davies,et al. Thyrotrophin receptor binding, intracellular cyclic AMP levels and iodine release in isolated thyroid cells , 1976, FEBS letters.
[36] F. Albright,et al. THE METABOLIC EFFECTS OF STEROID HORMONES IN OSTEOPOROSIS. , 1947, The Journal of clinical investigation.